跳至主要内容
临床试验/NCT05247424
NCT05247424已完成4 期

Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction

University Medical Centre Ljubljana1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2022年3月10日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
600
试验地点
1
主要终点
TIMI flow

研究概览

简要总结

Rupture of a coronary artery plaque leads to thrombotic occlusion of the coronary artery and would present as ST segment elevation myocardial infarction. Early treatment with aspirin and early primary percutaneous coronary intervention are indicated. Anticoagulation therapy, usually with unfractionated heparin, is required during percutaneous coronary intervention.

Investigators hypothesis is that pretreatment with unfractionated heparin in addition to aspirin at first medical contact may facilitate spontaneous reperfusion of culprit artery and procedural thrombotic complication in patients with ST elevation myocardial infarction without significant risk of bleeding complications.

详细描述

Randomization of patients with STEMI at first medical contact in a 1:1 ratio into an intervention group receiving 100 IU of unfractionated heparin (UFH) per kilogram of body weight IV and later additionally UFH after diagnostic coronary angiography according to the activated clotting time (ACT) and a control group receiving only UFH after diagnostic coronary angiography at the dose of 100 IU per kilogram of body weight.

The primary end point of the study is TIMI flow at coronary angiography. Secondary endpoints are: Bleeding complications (defined by BARC score), occurrence of cardiogenic shock, and 30-day mortality.

Investigators plan to randomize 600 patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Interventional cardiologists evaluating coronary angiography will be blinded to assigned group

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with STEMI referred for primary PCI
  • Duration of symptoms less than 6 hours before presentation

排除标准

  • Pregnancy
  • Cardiogenic shock at presentation (hemodynamic instability)
  • Cardiac arrest before randomization
  • Duration of symptoms for more than 6 hours before presentation

研究组 & 干预措施

Early unfractionated heparin

Experimental

Administration of UFH at a dose of 100 IU/kg body weight at first medical contact. Addition of UFH before coronary intervention according to ACT measurement after coronary angiography before coronary intervention.

干预措施: Unfractionated heparin (Drug)

结局指标

主要结局

TIMI flow

时间窗: Day 0

TIMI flow in culprit coronary artery at first coronary angiography

次要结局

  • Bleeding(Day 0)
  • Troponin I concentration 24 h after primary PCI(24 h)
  • Cardiogenic shock(Day 0 to 10)
  • 30 day mortality after STEMI(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peter Radsel

Head of intensive internal medicine department

University Medical Centre Ljubljana

研究点 (1)

Loading locations...

相似试验